CDMOHUBCDMOHUB
Pricing
    CDMOHUBCDMOHUB
    Pricing
    CDMOHUBCDMOHUB
    Pricing
    CDMOHUBCDMOHUB
    Pricing
    1. Home
    2. /CDMOs
    3. /Zhejiang Hisoar Pharmaceutical Co Ltd

    Zhejiang Hisoar Pharmaceutical Co Ltd

    CDMO
    China
    https://www.hisoar.com/

    Is this your company? Claim this profile

    Drug Product
    Drug Substance
    Analytical & Bioanalytical Services
    Excipients & Specialty Ingredients
    Company Overview

    About

    Zhejiang Hisoar Pharmaceutical Co., Ltd. (stock code 002099, Shenzhen Exchange), founded in 1966 and headquartered in Taizhou, Zhejiang, China, is a diversified pharmaceutical and chemical company with ~3,000 employees and 426 R&D personnel. Their pharmaceutical division produces specialty APIs, intermediates, formulations, and fine chemicals -- specifically antibiotics (penem/carbapenem series, clindamycin series), cardiovascular agents, and anti-diabetic APIs. Over 70% of products are exported. They also have a major dye/pigment business segment (~70% global market share in Reactive Blue KN-R). The company has 3 FDA-registered FEI numbers for API manufacture, 7 FDA inspections (4 NAI, 3 VAI, 0 OAI), 2 FDA-approved products (capsule, tablet), 40+ invention patents, and partnerships with Boehringer Ingelheim, Merck, Sanofi, Novartis, GSK, and others. Classified as API manufacturer because the core pharma business is own-brand API and intermediate production with limited CDMO positioning, though PharmaSource lists them under CMO/CDMO.

    Key Expertise

    carbapenem/penem antibiotics API, clindamycin series, anti-diabetic APIs, chiral drug intermediates, large-scale chemical synthesis

    Therapeutic Areas

    Infectious Disease
    Cardiovascular
    Quick Facts
    HQ:China
    Capabilities & Services

    Core Capabilities

    • Small Molecule API
    • API Manufacturing
    • Process Development

    Dosage Forms

    Oral Solid Dose

    Production Scales

    Commercial Scale

    Markets Served

    Asia
    Manufacturing Facilities

    1 site worldwide

    Zhejiang Hisoar Pharmaceutical Co Ltd - China Facility

    China
    View on Map

    Site Capabilities

    3 capabilities
    Formulation Development
    Process Development
    Scale-up
    Clinical Trial Experience

    Involvement in 1 clinical trial

    Therapeutic Areas
    Infectious Disease
    Certifications

    FDA Registration

    U.S. Food and Drug Administration
    Request an Introduction

    Please log in to contact this provider.

    Key facts about Zhejiang Hisoar Pharmaceutical Co Ltd

    • Zhejiang Hisoar Pharmaceutical Co Ltd is headquartered in China.
    • Zhejiang Hisoar Pharmaceutical Co Ltd has one manufacturing site listed on CDMO Hub, in China.
    • Zhejiang Hisoar Pharmaceutical Co Ltd's capabilities include Small Molecule API, API Manufacturing and Process Development.

    Find CDMOs like Zhejiang Hisoar Pharmaceutical Co Ltd

    Directory pages this company appears in, each with the full list of matching manufacturers.

    CDMOs in ChinaCDMOs in AsiaSmall Molecule API CDMOsOral Solid Dose CDMOs
    CDMOHUB

    Connecting biotech and pharma teams with contract manufacturing partners worldwide.

    Platform

    • Find CDMOs
    • CDMO Matchmaking
    • Expert Matchmaking
    • SmartRFI
      Members
    • Modality Guides
    • Supplier Maps
    • Join as Partner

    Company

    • Blog
    • Briefings
    • About Us
    • Contact

    Legal

    • Terms of Service
    • Privacy Policy

    © 2026 CDMOHUB. All rights reserved.

    CDMO Hub, Inc. Registered in Delaware, USA